• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Endocrinol Metab . Diabetes Increases Severe COVID-19 Outcomes Primarily in Younger Adults

tetano

Editor, Senior Moderator
J Clin Endocrinol Metab


. 2021 Aug 18;106(9):e3364-e3368.
doi: 10.1210/clinem/dgab393.
Diabetes Increases Severe COVID-19 Outcomes Primarily in Younger Adults


Marc Diedisheim[SUP] 1 2 [/SUP], Etienne Dancoisne[SUP] 3 4 [/SUP], Jean-François Gautier[SUP] 1 5 [/SUP], Etienne Larger[SUP] 2 [/SUP], Emmanuel Cosson[SUP] 6 7 [/SUP], Bruno Fève[SUP] 8 9 10 [/SUP], Philippe Chanson[SUP] 11 12 [/SUP], Sébastien Czernichow[SUP] 13 14 [/SUP], Sopio Tatulashvili[SUP] 6 7 [/SUP], Marie-Laure Raffin-Sanson[SUP] 15 16 [/SUP], Kankoé Sallah[SUP] 4 [/SUP], Muriel Bourgeon[SUP] 17 [/SUP], Christiane Ajzenberg[SUP] 18 [/SUP], Agnès Hartemann[SUP] 19 [/SUP], Christel Daniel[SUP] 3 20 [/SUP], Thomas Moreau[SUP] 21 [/SUP], Ronan Roussel[SUP] 1 22 [/SUP], Louis Potier[SUP] 1 22 [/SUP]



Affiliations

Abstract

Context: Diabetes is reported as a risk factor for severe coronavirus disease 2019 (COVID-19), but whether this risk is similar in all categories of age remains unclear.
Objective: To investigate the risk of severe COVID-19 outcomes in hospitalized patients with and without diabetes according to age categories.
Design setting and participants: We conducted a retrospective observational cohort study of 6314 consecutive patients hospitalized for COVID-19 between February and 30 June 2020 in the Paris metropolitan area, France; follow-up was recorded until 30 September 2020.
Main outcome measure(s): The main outcome was a composite outcome of mortality and orotracheal intubation in subjects with diabetes compared with subjects without diabetes, after adjustment for confounding variables and according to age categories.
Results: Diabetes was recorded in 39% of subjects. Main outcome was higher in patients with diabetes, independently of confounding variables (hazard ratio
1.13 [1.03-1.24]) and increased with age in individuals without diabetes, from 23% for those <50 to 35% for those >80 years but reached a plateau after 70 years in those with diabetes. In direct comparison between patients with and without diabetes, diabetes-associated risk was inversely proportional to age, highest in <50 years and similar after 70 years. Similarly, mortality was higher in patients with diabetes (26%) than in those without diabetes (22%, P < 0.001), but adjusted HR for diabetes was significant only in patients younger than age 50 years (HR 1.81 [1.14-2.87]).
Conclusions: Diabetes should be considered as an independent risk factor for the severity of COVID-19 in young adults more so than in older adults, especially for individuals younger than 70 years.

Keywords: age; covid-19; diabetes; mortality.
 
Back
Top Bottom